Encephalomyelitis, Venezuelan Equine - 5 Studies Found
Withdrawn |
: Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine : Venezuelan Equine Encephalitis : 2005-04-27 : Biological: VEE 3526 |
Enrolling by invitation |
: Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine : Venezuelan Equine Encephalomyelitis : 2007-12-19 : Biological: VEE TC-83 Subjects will receive a single 0.5 mL dose by subcutaneous route in the upper oute |
Suspended |
: Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83 : Venezuelan Equine Encephalomyelitis : 2007-12-19 : Biological: VEE C-84 Subjects will receive a 0.5 mL subcutaneous injection in the upper outer aspect of |
Completed |
: Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers : Venezuelan Equine Encephalitis Virus Infection : 2013-09-23 :
|
Not yet recruiting |
: Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults : Venezuelan Equine Encephalomyelitis Virus Disease : 2017-02-09 : Biological: VEE Vaccine 0.5 mL of VEE vaccine administered subcutaneously in the upper outer aspect of t |